Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Gisbert

Showing results (301-310 of 317) with videos related to

Pageof 32
Sort By:
Alimentary Pharmacology & Therapeutics|June 22, 2019
Real-world short-term effectiveness of ustekinumab in 305 patients with Crohn's disease: results from the ENEIDA registryM Iborra, B Beltrán, A Fernández-Clotet, et al.
Gut|January 6, 2017
Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximabD Laharie, A Bourreille, J Branche, et al.
Alimentary Pharmacology & Therapeutics|August 29, 2013
Smoking does influence disease behaviour and impacts the need for therapy in Crohn's disease in the biologic eraT Nunes, M J Etchevers, E Domènech, et al.
The American Journal of Gastroenterology|May 2, 2018
Post-operative morbidity and mortality of a cohort of steroid refractory acute severe ulcerative colitis: Nationwide multicenter study of the GETECCU ENEIDA RegistryI Ordás, E Domènech, M Mañosa, et al.
The American Journal of Gastroenterology|May 24, 2017
Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida RegistryMaría Chaparro, M Ramas, J M Benítez, et al.
The American Journal of Gastroenterology|January 16, 2013
Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel diseaseM J Casanova, M Chaparro, E Domènech, et al.
Alimentary Pharmacology & Therapeutics|July 5, 2011
Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patientsY González-Lama, F Bermejo, A López-Sanromán, et al.
Journal of Crohn'S & Colitis|April 13, 2019
Effectiveness and Safety of the Switch from Remicade® to CT-P13 in Patients with Inflammatory Bowel DiseaseM Chaparro, A Garre, M F Guerra Veloz, et al.
Alimentary Pharmacology & Therapeutics|January 26, 2018
Phenotype and natural history of elderly onset inflammatory bowel disease: a multicentre, case-control studyM Mañosa, M Calafat, R de Francisco, et al.
Journal of Crohn'S & Colitis|February 6, 2019
Prevalence and Factors Associated With Fatigue in Patients With Inflammatory Bowel Disease: A Multicentre StudyC Chavarría, M J Casanova, M Chaparro, et al.
Pageof 32

Showing results (301-310 of 317) with videos related to

Sort By:
Pageof 32
Alimentary Pharmacology & Therapeutics|June 22, 2019
Real-world short-term effectiveness of ustekinumab in 305 patients with Crohn's disease: results from the ENEIDA registryM Iborra, B Beltrán, A Fernández-Clotet, et al.
Gut|January 6, 2017
Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximabD Laharie, A Bourreille, J Branche, et al.
Alimentary Pharmacology & Therapeutics|August 29, 2013
Smoking does influence disease behaviour and impacts the need for therapy in Crohn's disease in the biologic eraT Nunes, M J Etchevers, E Domènech, et al.
The American Journal of Gastroenterology|May 2, 2018
Post-operative morbidity and mortality of a cohort of steroid refractory acute severe ulcerative colitis: Nationwide multicenter study of the GETECCU ENEIDA RegistryI Ordás, E Domènech, M Mañosa, et al.
The American Journal of Gastroenterology|May 24, 2017
Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida RegistryMaría Chaparro, M Ramas, J M Benítez, et al.
The American Journal of Gastroenterology|January 16, 2013
Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel diseaseM J Casanova, M Chaparro, E Domènech, et al.
Alimentary Pharmacology & Therapeutics|July 5, 2011
Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patientsY González-Lama, F Bermejo, A López-Sanromán, et al.
Journal of Crohn'S & Colitis|April 13, 2019
Effectiveness and Safety of the Switch from Remicade® to CT-P13 in Patients with Inflammatory Bowel DiseaseM Chaparro, A Garre, M F Guerra Veloz, et al.
Alimentary Pharmacology & Therapeutics|January 26, 2018
Phenotype and natural history of elderly onset inflammatory bowel disease: a multicentre, case-control studyM Mañosa, M Calafat, R de Francisco, et al.
Journal of Crohn'S & Colitis|February 6, 2019
Prevalence and Factors Associated With Fatigue in Patients With Inflammatory Bowel Disease: A Multicentre StudyC Chavarría, M J Casanova, M Chaparro, et al.
Pageof 32